TG-C

BIOLOGICAL3 trials

Sponsors

Kolon TissueGene, Inc.

Conditions

Degenerative Osteoarthritis

Phase 2

A Study to Determine the Safety and Efficacy of TG-C in Subjects With Symptomatic Early Hip Osteoarthritis

Not yet recruitingNCT05276011

Kolon TissueGene, Inc.Degenerative Osteoarthritis

Start: 2027-10-01End: 2028-10-01Target: 255Updated: 2026-08-20

Phase 3

A Study to Determine the Safety and Efficacy of TG-C in Subjects With Kellgren and Lawrence Grade 2 or 3 OA of the Knee

Active, not recruitingNCT03203330

Kolon TissueGene, Inc.Degenerative Osteoarthritis

Start: 2018-10-30End: 2026-08-18Updated: 2026-08-20

Study to Determine the Efficacy and Safety of TG-C in Subjects With Kellgren/Lawrence Grade 2 or 3 OA of the Knee

CompletedNCT03291470

Kolon TissueGene, Inc.Degenerative Osteoarthritis

Start: 2021-12-09End: 2026-05-01Updated: 2026-08-20